Accent Therapeutics Announces $63 Million Series B Financing to Advance Novel, Precision Cancer Therapies Targeting RNA-Modifying Proteins

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2VVYfGW
via IFTTT